Pfizer (PFE) Business News

Track Pfizer in real time with a live news feed covering Pfizer stock news, official press releases, company announcements, and an archive of historical Pfizer news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
news photo
Loading...

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

Read full article redirect
12:32 PM | Friday | Jun 12, 2026

Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

Fool - Investing News

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

Read full article arrow
News Thumbnail
10:47 AM | Friday | Jun 12, 2026

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

24/7 Wall Street

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to own right now, a $1.02 trillion obesity juggernaut that has ripped 20.9% higher in a single month on the back of the

Read full article arrow
News Thumbnail
11:36 AM | Thursday | Jun 11, 2026

Why Pfizer Stock Popped Today

Fool - Investing News

Pfizer stock may not be cheap enough to buy yet, but it's certainly too cheap to sell.

Read full article arrow
News Thumbnail
9:45 AM | Thursday | Jun 11, 2026

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?

Fool - Investing News

One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow. See how their fundamentals stack up.

Read full article arrow
News Thumbnail
7:59 AM | Wednesday | Jun 10, 2026

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

247 Wallst

Pre-Market Stock Futures: Futures are trading lower after the stock market tried to take a cue from Monday's action, and things didn't work out quite as well on Tuesday. Once again, the market gapped open higher as the "Buy the dip" legions came in to ride what they thought would be another wave higher, only... Here Are Wednesday's Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

Read full article arrow
News Thumbnail
7:56 AM | Wednesday | Jun 10, 2026

Pfizer CEO warns German investment at risk over drug pricing policies

Reuters

Pfizer is ‌reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said ​in a letter to Chancellor Friedrich ​Merz, citing the government's policy proposals ⁠that would lower drug prices.

Read full article arrow
News Thumbnail
2:06 AM | Wednesday | Jun 10, 2026

Prediction: Pfizer Stock Will Double on This Date

24/7 Wall Street

Pfizer (NYSE:PFE | PFE Price Prediction) trades at $25.62, pays a 6.7% dividend yield, and just posted five straight quarterly EPS beats before stumbling in Q1.

Read full article arrow
News Thumbnail
11:56 AM | Tuesday | Jun 9, 2026

PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi

Zacks Investment Research

Pfizer wins FDA approval to expand Hympavzi's use in additional hemophilia A and B patient groups, including children with inhibitors.

Read full article arrow
News Thumbnail
9:20 AM | Tuesday | Jun 9, 2026

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Forbes

More employers and health plans are balking at paying for costly GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and the treatment of obesity, according to a new report.

Read full article arrow
News Thumbnail
11:57 AM | Monday | Jun 8, 2026

Watch Out, Rising Capex Could Turn Today's Cash Cows Into Dogs

24/7 Wall Street

Pacer US Cash Cows 100 ETF (NYSEARCA:COWZ) owns the 100 Russell 1000 names that generate the most free cash flow relative to market value.

Read full article arrow
News Thumbnail